Omarigliptina is a pyrrolopyrazole compound used as an active pharmaceutical ingredient. It has been investigated in research related to type 2 diabetes mellitus and chronic renal insufficiency.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1226781-44-7
Seractide
pharmaceutical raw material
Ifebemtinib
pharmaceutical raw material
Gadodiamide hydrate
pharmaceutical raw material
Balovaptan
pharmaceutical raw material
Cofrogliptin
pharmaceutical raw material
(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine
MKMPWKUAHLTIBJ-ISTRZQFTSA-N
CS(=O)(=O)N1C=C2CN(CC2=N1)[C@@H]3C[C@@H]([C@H](OC3)C4=C(C=CC(=C4)F)F)N